Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19".
作者信息
Buonomo Antonio Riccardo, Viceconte Giulio, Gentile Ivan
机构信息
Department of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 80130, Naples, Italy.
出版信息
Crit Care. 2021 Dec 6;25(1):418. doi: 10.1186/s13054-021-03836-7.
Abstract
摘要
相似文献
1
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19".新型冠状病毒肺炎合并耶氏肺孢子菌肺炎：一种被忽视的临床实体——对“与新型冠状病毒肺炎相关或不相关的病毒性急性呼吸窘迫综合征患者中肺孢子菌肺炎的风险”的回应
Crit Care. 2021 Dec 6;25(1):418. doi: 10.1186/s13054-021-03836-7.
2
Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19.与新型冠状病毒肺炎（COVID-19）相关或不相关的病毒性急性呼吸窘迫综合征患者发生肺孢子菌肺炎的风险
Crit Care. 2021 Sep 26;25(1):348. doi: 10.1186/s13054-021-03767-3.
3
Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient.一名25岁严重免疫功能低下患者同时感染新冠病毒和耶氏肺孢子菌肺炎。
Int J Infect Dis. 2020 Oct;99:119-121. doi: 10.1016/j.ijid.2020.07.061. Epub 2020 Aug 5.
4
Pneumocystis jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection.一名新诊断为HIV-1感染患者的耶氏肺孢子菌肺炎与严重急性呼吸综合征冠状病毒2合并感染
Clin Infect Dis. 2021 Apr 26;72(8):1487-1489. doi: 10.1093/cid/ciaa906.
5
Non-HIV Immunocompetent Patient with COVID-19 and Severe Pneumocystis jirovecii Pneumonia Co-Infection.非 HIV 免疫功能健全的 COVID-19 患者合并严重肺孢子菌肺炎感染。
Emerg Infect Dis. 2024 Sep;30(9):1948-1952. doi: 10.3201/eid3009.240615.
6
Pneumocystis pneumonia in the COVID-19 pandemic era: similarities and challenges.COVID-19 大流行时代的肺孢子菌肺炎：相似性与挑战。
Trends Parasitol. 2021 Oct;37(10):859-862. doi: 10.1016/j.pt.2021.07.010. Epub 2021 Aug 4.
7
A Case of COVID-19 and Coinfection.一例新型冠状病毒肺炎合并感染病例
Am J Respir Crit Care Med. 2020 Jul 1;202(1):136-138. doi: 10.1164/rccm.202003-0766LE.
8
[Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].[新型冠状病毒肺炎后非艾滋病患者的耶氏肺孢子菌肺炎]
Rev Chilena Infectol. 2022 Jun;39(3):357-360. doi: 10.4067/s0716-10182022000200357.
9
Pneumocystis jirovecii and SARS-CoV-2 Coinfection as Presentation of X-linked Severe Combined Immunodeficiency.耶氏肺孢子菌与严重急性呼吸综合征冠状病毒2型合并感染作为X连锁严重联合免疫缺陷病的表现
Indian J Pediatr. 2023 Aug;90(8):832-833. doi: 10.1007/s12098-023-04661-2. Epub 2023 May 30.
10
The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症患者中耶氏肺孢子菌的存在情况。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.10.034. Epub 2020 Nov 4.
引用本文的文献
1
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves.COVID-19住院患者的侵袭性真菌感染：第一波疫情期间非重症监护单中心经验
J Fungi (Basel). 2023 Jan 6;9(1):86. doi: 10.3390/jof9010086.
2
Should SARS CoV-2 Infection be Considered an Independent Risk Factor for Pneumonia? Emerging Data after Two Years of Pandemic from a Single Center Experience.新型冠状病毒感染应被视为肺炎的独立危险因素吗？来自单一中心两年大流行后的新数据。
Rev Recent Clin Trials. 2022;17(3):220-222. doi: 10.2174/1574887117666220511123826.
本文引用的文献
1
Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience.非 HIV 患者在 COVID-19 康复后的肺炎：单中心经验。
Int J Environ Res Public Health. 2021 Oct 29;18(21):11399. doi: 10.3390/ijerph182111399.
2
Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19.与新型冠状病毒肺炎（COVID-19）相关或不相关的病毒性急性呼吸窘迫综合征患者发生肺孢子菌肺炎的风险
Crit Care. 2021 Sep 26;25(1):348. doi: 10.1186/s13054-021-03767-3.
3
pneumonia in an immunocompetent patient recovered from COVID-19.新冠肺炎康复后免疫功能正常患者的肺炎。
Infect Dis (Lond). 2021 May;53(5):382-385. doi: 10.1080/23744235.2021.1890331. Epub 2021 Mar 1.
4
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.血清（1-3）-β-D-葡聚糖检测对肺孢子菌肺炎的诊断准确性：系统评价和荟萃分析。
Clin Microbiol Infect. 2020 Sep;26(9):1137-1143. doi: 10.1016/j.cmi.2020.05.024. Epub 2020 May 30.
5
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.侵袭性真菌病的共识定义修订与更新：来自欧洲癌症研究与治疗组织和真菌病研究组教育与研究联合会。
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008.
6
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.欧洲癌症研究与治疗组织/侵袭性真菌感染合作组和美国国立过敏与传染病研究所真菌病研究组（EORTC/MSG）共识组对侵袭性真菌病的修订定义。
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.
7
Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy.无获得性免疫缺陷综合征患者的卡氏肺孢子虫肺炎：相关疾病及既往皮质类固醇治疗情况
Mayo Clin Proc. 1996 Jan;71(1):5-13. doi: 10.4065/71.1.5.
Zotero 插件